{
  "docId": "019de073-7e4e-7689-a01c-e0840dac2b61",
  "docSlug": "97e34d6c4db7d9454440fee3efd43545",
  "documentTitle": "Axcella Health | Results Presentation Deck | 62 slides",
  "authorId": "axcella-health",
  "authorName": "Axcella Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 24,
  "pageCount": 62,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a central biological pathway diagram (liver-centric) surrounded by comparative tables showing single-target drugs vs AXA1125's multi-target approach.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-7e4e-7689-a01c-e0840dac2b61/24",
  "deckHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61",
  "deckJsonHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61.json",
  "deckAnchorHref": "/decks/019de073-7e4e-7689-a01c-e0840dac2b61#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.424,
        "x": 0.288,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "Central biological pathway map of NASH disease drivers in the liver",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89279d35-a34c-438c-936c-6ba633dc5f06",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.72,
        "y": 0.2
      },
      "kind": "table",
      "text": "Inflammation: Single Targets vs AXA1125",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0dfdddfa-ccf7-48c7-8f3a-9109690eb2fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "table",
      "text": "Metabolism: Single Targets vs AXA1125",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ec641b1-7daf-4ce7-a59f-d934bcb80152",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.72,
        "y": 0.7
      },
      "kind": "table",
      "text": "Fibrosis: Single Targets vs AXA1125",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7fc30d65-81c8-4b72-9c52-90b7c89f0bc4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.7,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "AXA1125 is Multi-Targeted by Design Against Key Pathways across NASH Disease Drivers",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be6b803f-a667-40d2-8be5-f97e9d5b3432",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "NASH is a Complex Disease with Pleiotropic Disease Pathways",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17bfb576-3e2e-4cdd-8ac0-d87d07becd96",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "causal-chain",
      "slug": null,
      "matchId": "7933b6d2-735c-44ef-b7d9-a9b03edde098",
      "evidence": "The central diagram maps biological drivers to disease outcomes in NASH.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 36,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "de6af44a-f17d-4c55-adca-ab6e25c41e5d",
      "evidence": "The presentation highlights the need for effective treatment options and the risks associated with disease progression",
      "position": 0,
      "objective": "What is the risk of not treating NASH effectively?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 30,
      "from": 24,
      "name": "Value Chain Walk",
      "slug": "44-value-chain-walk",
      "bestFor": "Operations improvement, cost reduction, competitive advantage",
      "matchId": "f1102384-67e2-4c89-b8e5-8eb2f1230b26",
      "evidence": "The presentation describes the multi-targeted impact of AXA1125 on NASH disease pathways",
      "position": 1,
      "objective": "How does AXA1125 address the complex disease pathways of NASH?",
      "structure": "Input -> Process Step 1 -> Process Step 2 -> Process Step 3 -> Output -> Value Assessment",
      "confidence": 0.6,
      "description": "Walk through each step of the value chain to identify where value is created or destroyed"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}